🇺🇸 FDA
Patent

US 11939343

Sting agonist compounds and methods of use

granted A61PA61P1/16A61P3/04

Quick answer

US patent 11939343 (Sting agonist compounds and methods of use) held by Mersana Therapeutics, Inc. expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Mersana Therapeutics, Inc.
Grant date
Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P1/16, A61P3/04, A61P3/06, A61P31/12